We study how structural and functional imaging measures relate to the biology of neurological and psychiatric conditions. Multimodal MRI and computational analyses are combined with reference maps of neurotransmitter systems, cellular organisation and gene expression. This allows regional imaging findings to be examined within a broader neurobiological framework.
A central question is whether an observed imaging pattern is reproducible across datasets and informative about the processes underlying a clinical phenotype.
One line of research relates regional cortical thickness trajectories to cellular and neurochemical organisation. Work led by Dr. Leon Lotter shows that these relationships change across development and ageing, with complementary evidence from developmental gene expression and longitudinal adolescent imaging. A related line of work examines how cytoarchitectural differences within large-scale networks relate to wiring and the direction of signal flow.
Our work in autism, for example, relates local resting-state activity differences to neurotransmitter distributions and experimentally induced pharmacological changes. These analyses concern group-level relationships; their translation into individual-level biomarkers requires further validation.
Methodological development supports this research. JuSpace and NiSpace provide tools for spatial comparisons between neuroimaging maps and molecular or cellular atlases, including statistical procedures that account for spatial structure.
Examples:
Lotter et al., Nature Communications (2024) ·
Grumbach et al., Nature Communications (2025)